Clinical trial
Massive Nasal Bleeding in Patients With Nasopharyngeal Carcinoma Received Curative Radiotherapy
NCT06348485 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Massive Nasal Bleeding in Patients With Nasopharyngeal Carcinoma Received Curative Radiotherapy
- Lead sponsor
- Taichung Veterans General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 1994
- Completion date
- February 29, 2024
- Enrollment
- 1,327 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nasopharyngeal carcinoma patients treated with curative radiotherapy